Objetive

To describe the experience regarding the strategy implemented to enhance safety during the administration of hazardous drugs recommended for rapid sequence intubation in patients with COVID-19.

Materials and Methods

A descriptive experience-reporting study was conducted based on the principles of the National Patient Safety Policy, which describe the adequacy of color-coded trays for administering hazardous drugs during the rapid sequence intubation. According to the sequence of drug administration, drugs are classified into their therapeutic class in color-coded trays. The strategy was implemented in partnership with the ICU multidisciplinary team from a public cardiovascular hospital in Rio de Janeiro.

Results

Color-coded trays were used three times during the rapid sequence intubation. A table was prepared based on this strategy which contained pharmacological and nursing care characteristics of hazardous drugs available in the medication preparation room for consultations. Medication Without Harm is included in the third WHO Global Patient Safety Challenge. Among the factors that contribute to the incidence of adverse effects is the use of hazardous drugs. The application of safety barriers is the strategy outlined in this report, which is necessary for the prevention of adverse effects.

Conclusions

The use of color-coded trays set up barriers to the occurrence of possible incidents derived from the use of hazardous drugs during the rapid sequence intubation in patients with COVID-19.

        · abstract in Portuguese | Spanish     · text in Portuguese     · Portuguese ( pdf )